72,833 65,654 8% 287,539 255,800 12% (2) Cost of sales 59,325 59,992 55,963 6% 240,753 218,097 10% Gross profit 11,683 12,841 9,691 21% 46,786 37,703 24% (2) Selling and administrative expenses 6,120 5,953
6,571.94 4,820.69 8,509.45 Costs 824.35 319.35 1,012.49 1,689.93 3,192.51 Selling And Administrative Expenses 999.28 791.78 1,841.35 2,141.44 3,757.26 Total Cost And Expenses 2,315.65 1,616.74 5,280.10
profit 12,582 11,162 13,663 (8)% 58,932 48,498 22% Selling and administrative expenses2 8,274 7,569 6,064 36% 29,949 23,875 25% Foreign exchange gain (loss) 99 175 214 (54)% 471 216 118% EBITDA 8,393 7,937
and administrative expenses2 8,274 7,569 6,064 36% 29,949 23,875 25% Foreign exchange gain (loss) 99 175 214 (54)% 471 216 118% EBITDA 8,393 7,937 10,863 (23)% 44,658 37,189 20% Depreciation and
profit 13,291 12,582 15,885 (16)% 56,338 54,071 4% Selling and administrative expenses2 8,806 8,274 6,770 30% 31,984 24,907 28% Foreign exchange gain (loss) (179) 99 355 (150)% (63) 621 (110)% EBITDA 8,616
Selling and Administrative Expenses Outstanding of Payables at the end of the period 226 10 102 23 No. 4.1- Purchasing No. 3 –Trade and Other Payables (Part 2/2) The Company bought denture materials from
financial lease 794 665 567 124 Cost of sales (49,371) (38,479) (37,721) (9,093) Gross profit 14,854 14,088 13,158 3,382 Other income 49 258 334 147 Administrative expenses (776) (954) (847) (147) Finance
3,382 Other income 49 258 334 147 Administrative expenses (776) (954) (847) (147) Finance cost (3,244) (2,599) (2,380) (518) Profit before income tax expenses 10,768 11,044 11,577 3,265 Income tax
administrative expenses2 6,770 6,064 5,738 18% 24,907 22,273 12% Foreign exchange gain (loss) 355 214 (49) 621 535 16% EBITDA 12,688 10,863 7,399 71% 42,479 31,302 36% Depreciation and amortization 3,218 3,051